Crossmark Large Cap Growth ETF (CLCG)

Currency in USD
24.80
-0.40(-1.59%)
Closed·
After Hours
24.800.00(0.00%)
·
Trading near 52-week Low
Day's Range
24.6924.83
52 wk Range
24.6925.45

Key Statistics

Morning Star Rating
-
Risk Rating
-
Bid / Ask
-
Prev. Close
25.20
Price Open
24.69
Volume
2,764
Average Vol. (3m)
7,547
1-Year Change
-
Day’s Range
24.69-24.83
52-Week Range
24.69-25.45
Market Cap
691.32B
Expense Ratio
0.50%
How do you feel today about CLCG?
Vote to see community's results!
or

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
NVDA15.70%173.72-2.33%1,130
MSFT10.48%524.11-1.76%260
AAPL8.31%202.38-2.50%494
AVGO6.36%288.64-1.72%275
V3.91%339.35-1.77%140
NFLX3.69%1,158.60-0.07%40
MA3.57%559.89-1.16%80
AMZN3.20%214.75-8.27%175
INTU2.83%776.15-1.14%45
NOW2.71%914.37-3.05%35

Crossmark Large Cap Growth ETF Company Profile

Crossmark ETF Trust - Crossmark Large Cap Growth ETF is an exchange traded fund launched and managed by Crossmark Global Investments, Inc. It invests in public equity markets. The fund invests in stocks of companies operating across diversified sectors. The fund invests in growth stocks of large-cap companies, within the market capitalization range of the Russell 1000 Growth Index. It invests in stocks of companies that are deemed socially conscious in their business dealings. The fund employs fundamental and quantitative analysis to create its portfolio. The fund does not invest in stocks of companies operating across production, distribution, retail, supply or licensing of alcohol or related products, tobacco or related products, gambling, abortions and/or the production of drugs that are used to terminate pregnancy, leasing real estate to facilities providing abortions, scientific research using stem cells derived from human embryos, fetal tissue or human embryo cloning techniques, production of adult entertainment or materially involved in the distribution or retail of adult entertainment, production, distribution, retail, supply or licensing of psychoactive recreational cannabis or derivative products sectors. The fund employs external research to create its portfolio. Crossmark ETF Trust - Crossmark Large Cap Growth ETF was formed on July 23, 2025 and is domiciled in the United States.

Industry
-
Sector
-
0
Equity Type
ETF

FAQ

How is the performance of CLCG?

As of 03 Aug 2025, CLCG is trading at a price of 24.80, with a previous close of 25.20. The stock has fluctuated within a day range of 24.69 to 24.83, while its 52-week range spans from 24.69 to 25.45.

What is the current price of CLCG?

The CLCG stock price today is 24.80.

What is the P/E ratio of CLCG?

The P/E ratio for CLCG is 28.61.

From a Technical Analysis Perspective, Is CLCG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What is the CLCG market cap?

The market cap for CLCG is 495.98K.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.